Publications by authors named "Graham H Jackson"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

117

Total Likes

80

Extended Reach

242,786

Social Features

43
G
Genomic Classification and Individualized Prognosis in Multiple Myeloma.
Francesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, Alexandra M Poos, Andriy Derkach, Graham H Jackson

J Clin Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance lenalidomide in newly diagnosed transplant eligible and non-eligible myeloma patients; profiling second primary malignancies in 4358 patients treated in the Myeloma XI Trial.
John R Jones, David A Cairns, Tom Menzies, Charlotte Pawlyn, Faith E Davies, Graham H Jackson

EClinicalMedicine· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from 'Myeloma XI', a multicentre, open-label, randomised, phase III trial.
Matthew W Jenner, Charlotte Pawlyn, Faith E Davies, Tom Menzies, Anna Hockaday, Graham H Jackson

Br J Haematol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic.
Jonathan Carmichael, Frances Seymour, Graham McIlroy, Sarrah Tayabali, Rosie Amerikanou, Graham H Jackson

Blood Cancer J· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biallelic TET2 mutations confer sensitivity to 5'-azacitidine in acute myeloid leukemia.
Friedrich Stölzel, Sarah E Fordham, Devi Nandana, Wei-Yu Lin, Helen Blair, Graham H Jackson

JCI Insight· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining FiTNEss for treatment for multiple myeloma.
Gordon Cook, Charlotte Pawlyn, David A Cairns, Graham H Jackson

Lancet Healthy Longev· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal Residual Disease After Autologous Stem-Cell Transplant for Patients With Myeloma: Prognostic Significance and the Impact of Lenalidomide Maintenance and Molecular Risk.
Ruth M de Tute, Charlotte Pawlyn, David A Cairns, Faith E Davies, Tom Menzies, Graham H Jackson

J Clin Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and outcomes of IgD myeloma: experience across UK national trials.
Charles Agbuduwe, Gulnaz Iqbal, David Cairns, Tom Menzies, Janet Dunn, Graham H Jackson

Blood Adv· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Etiological Cytogenetic Abnormalities on the Depth of Immunoparesis and Survival in Newly Diagnosed Multiple Myeloma.
Jessica Caro, David Cairns, Tom Menzies, Eileen Boyle, Charlotte Pawlyn, Graham H Jackson

Clin Lymphoma Myeloma Leuk· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia.
Wei-Yu Lin, Sarah E Fordham, Eric Hungate, Nicola J Sunter, Claire Elstob, Graham H Jackson

Nat Commun· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of lenalidomide for maintenance treatment of patients with multiple myeloma following autologous stem cell transplantation.
John R Jones, Charlotte Pawlyn, Graham H Jackson

Expert Opin Drug Saf· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide association study identifies susceptibility loci for acute myeloid leukemia.
Wei-Yu Lin, Sarah E Fordham, Eric Hungate, Nicola J Sunter, Claire Elstob, Graham H Jackson

Nat Commun· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide before and after autologous stem cell transplantation for transplant-eligible patients of all ages in the randomized, phase III, Myeloma XI trial.
Graham H Jackson, Faith E Davies, Charlotte Pawlyn, David A Cairns, Alina Striha

Haematologica· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results from Myeloma XI, a multicentre, open-label, randomised, Phase III trial.
Graham H Jackson, Charlotte Pawlyn, David A Cairns, Alina Striha, Corinne Collett

Br J Haematol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials.
Luciano J Costa, Benjamin A Derman, Susan Bal, Surbhi Sidana, Saurabh Chhabra, Graham H Jackson

Leukemia· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial.
Graham H Jackson, Charlotte Pawlyn, David A Cairns, Ruth M de Tute, Anna Hockaday

PLoS Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor monocyte-derived macrophages promote human acute graft-versus-host disease.
Laura Jardine, Urszula Cytlak, Merry Gunawan, Gary Reynolds, Kile Green, Graham H Jackson

J Clin Invest· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombosis in patients with myeloma treated in the Myeloma IX and Myeloma XI phase 3 randomized controlled trials.
Charlotte A Bradbury, Zoe Craig, Gordon Cook, Charlotte Pawlyn, David A Cairns, Graham H Jackson

Blood· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy.
Gordon Cook, A John Ashcroft, Guy Pratt, Rakesh Popat, Karthik Ramasamy, Graham H Jackson

Br J Haematol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma.
Sarah A Bird, Graham H Jackson, Charlotte Pawlyn

Clin Hematol Int· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microhomology-mediated end joining drives complex rearrangements and overexpression of and in multiple myeloma.
Aneta Mikulasova, Cody Ashby, Ruslana G Tytarenko, Pingping Qu, Adam Rosenthal, Graham H Jackson

Haematologica· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response-adapted intensification with cyclophosphamide, bortezomib, and dexamethasone versus no intensification in patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial.
Graham H Jackson, Faith E Davies, Charlotte Pawlyn, David A Cairns, Alina Striha

Lancet Haematol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genes.
Molly Went, Ben Kinnersley, Amit Sud, David C Johnson, Niels Weinhold, Graham H Jackson

Hum Genomics· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physicians, paraproteins and progress: diagnosis and management of myeloma.
Charlotte Pawlyn, Graham H Jackson

Br J Hosp Med (Lond)· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis